The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells

NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer

(2018) Kuojun Zhang et al.   JOURNAL OF MEDICINAL CHEMISTRY

Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells

(2017) Siriwoot Butsri et al.   Oncology Letters

Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC

(2015) B. Madajewski et al.   MOLECULAR CANCER RESEARCH

Umbelliferone exhibits anticancer activity via the induction of apoptosis and cell cycle arrest in HepG2 hepatocellular carcinoma cells

(2015) SHI-MIN YU et al.   Molecular Medicine Reports

NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix

(2014) Yue Ma et al.   BMC CANCER

Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents

(2014) Ponsilp Zeekpudsa et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Clinical implications of high NQO1 expression in breast cancers

(2014) Yang Yang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

ABO Blood Group and Risk of Pancreatic Cancer in a Turkish Population in Western Blacksea Region

(2012) Huseyin Engin et al.   Asian Pacific Journal of Cancer Prevention

In vitro cell migration and invasion assays

(2012) Nina Kramer et al.   MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

Exploiting Tyrosinase Expression and Activity in Melanocytic Tumors

(2011) Ashley J. Vargas et al.   INTEGRATIVE CANCER THERAPIES

Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells

(2010) Benjaporn Buranrat   WORLD JOURNAL OF GASTROENTEROLOGY

Dicoumarol enhances doxorubicin-induced cytotoxicity in p53 wild-type urothelial cancer cells through p38 activation

(2009) Yoshiyuki Matsui et al.   BJU INTERNATIONAL